Ponesimod

N/A

Report date: 2024/01/04 15:28:10
NME

Base Information

Drug NamePonesimod
Drug Alias Name珀奈莫德ponesimodumponesimodCompound 8bo - ActelionPONVORY +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSphingosine 1-Phosphate Receptor 1 modulators
TargetsSphingosine 1-Phosphate Receptor 1
Therapy Area/IndicationsPlaque psoriasisGraft vs Host DiseasePsoriasis +[5] 
Global Approved IndicationsMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2021/03/18
Country/TerritoryCzechiaBelgiumBosnia and Herzegovina +[36] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesActelion Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJanssen-Cilag International NvVanda Pharmaceuticals IncActelion Pharmaceuticals Ltd +[4] 
Inactive CompaniesJanssen Pharmaceutical Nv
Active IndicationsPlaque psoriasisMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis
Inactive IndicationsGraft vs Host DiseasePsoriasis

Other Information

ATC CodeL04A
Related LinksWikipedia